Skip to main content
Savencia logo

Savencia — Investor Relations & Filings

Ticker · SAVE ISIN · FR0000120107 LEI · 5299006UH636V4UOZS07 PA Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2024-12-10 Share Issue/Capital Cha…
Country FR France
Listing PA SAVE

About Savencia

https://www.savencia-fromagedairy.com/e…

Savencia is an international, family-owned food group specializing in dairy products and specialty cheeses. As a leading producer of branded soft cheeses, its portfolio includes brands such as Caprice des Dieux, Saint Agur, Chaumes, and St Moret, utilizing cow's, goat's, and sheep's milk. The group's activities also extend to the fine delicatessen and chocolate sectors. Additionally, it provides sweet gastronomy products for the premium food service market and offers charcuterie and seafood brands in retail. The company operates with the mission of “Leading the way to better food,” focusing on sustainable and ethical growth.

Recent filings

Filing Released Lang Actions
SAVENCIA : actions et droits de vote - information mensuelle
Share Issue/Capital Change Classification · 95% confidence The document is a short, monthly regulatory disclosure regarding the total number of shares and voting rights for Savencia Fromage & Dairy. It does not fit into specific categories like dividend announcements, director dealings, or major shareholding notifications. As it is a standard monthly regulatory update required by market authorities, it falls under the general regulatory filings category.
2024-12-10 French
SAVENCIA : actions et droit de vote - information mensuelle
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Actions et droits de vote – information mensuelle" (Shares and voting rights – monthly information) and provides a snapshot of the total share capital and voting rights as of a specific date (October 31, 2024). This content relates to the structure of the company's capital and voting rights, which is often disclosed in regulatory updates or specific capital structure reports. Given the options, it is a periodic update concerning capital structure and voting rights. It is not a full Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). It most closely aligns with a general regulatory update or a specific capital/share structure notification. Since there isn't a perfect fit for 'Monthly Capital Structure Update', I must choose the best fit among the provided codes. 'SHA' (Share Issue/Capital Change) covers capital changes, and 'RNS' is the general regulatory fallback. Because this is a recurring, specific disclosure about the total number of shares and voting rights, it fits better under a general regulatory filing or a capital-related announcement. Given the focus on the total number of shares and voting rights, it is a specific disclosure about the capital structure. 'SHA' is for *issues* or *splits*, which this isn't directly, but it is related to capital structure. 'RNS' is the most appropriate fallback for specific, periodic regulatory disclosures that don't fit elsewhere. However, since it explicitly mentions 'capital social' (share capital) and 'droits de vote' (voting rights), it is a specific disclosure about the company's share base. I will classify this as a general Regulatory Filing (RNS) as it is a monthly update that doesn't match the specific definitions like DIV, SHA, or DVA (which is for voting *results*).
2024-12-10 French
Savencia : actions et droits de vote - information mensuelle
Regulatory Filings Classification · 95% confidence The document is a short monthly disclosure regarding the number of shares and voting rights for Savencia Fromage & Dairy as of September 30, 2024. This type of periodic regulatory disclosure regarding share capital and voting rights does not fit into specific categories like 'Major Shareholding' (which tracks individual investors) or 'Share Issue' (which tracks specific corporate actions). It is a standard regulatory filing required by market authorities, and since it does not fit other specific categories, it is classified as a Regulatory Filing (RNS).
2024-10-28 French
Savencia : actions et droits de vote - information mensuelle
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Actions et droits de vote – information mensuelle" (Shares and voting rights – monthly information) and provides a snapshot of the total number of shares and voting rights as of August 31, 2024. This type of regular, periodic disclosure regarding the capital structure and voting rights, especially when presented as a brief monthly update, most closely aligns with a general regulatory filing or a specific update related to share capital, but given the options, it is a specific disclosure about the number of shares and voting rights. Since there isn't a specific code for 'Monthly Share Capital Update', I must evaluate the closest fit. It is not an Earnings Release (ER), Interim Report (IR), or a Director's Dealing (DIRS). It is a notification about the total number of shares outstanding and voting rights, which is a fundamental aspect of capital structure. The closest relevant codes are 'SHA' (Share Issue/Capital Change) or 'RNS' (Regulatory Filings/Miscellaneous). Because this is a routine, periodic disclosure of the total share count rather than an announcement of a specific *change* (like a new issue or buyback), and it is a specific regulatory disclosure, 'RNS' (Regulatory Filings) serves as the best general fit for routine, non-standardized disclosures, although 'SHA' relates to capital structure. Given the context of routine monthly reporting on the total share count, 'RNS' is the most appropriate fallback for a specific, non-core financial report type.
2024-10-28 French
SAVENCIA : Activité à fin septembre 2024
Earnings Release Classification · 99% confidence The document is titled 'Communiqué de Presse : Activité à fin septembre 2024' (Press Release: Activity as of September 2024). It presents key financial figures (Chiffre d'affaires) for the period ending September 30, 2024, compared to 2023, and discusses business performance. This format—a brief announcement highlighting key results for a specific period (quarterly/interim)—is characteristic of an Earnings Release (ER). Although it contains some ESG mentions ('Engagements RSE'), the primary focus and structure are financial results announcement, not a full Interim Report (IR) or a standalone Audit Report (AR). Given the short length and focus on immediate results, ER is the most appropriate classification. 9M 2024
2024-10-24 French
SAVENCIA: Activity at the end of September 2024
Earnings Release Classification · 99% confidence The document is titled "Press Release: activity at the end of September 2024" and presents key financial figures (Sales) for the period ending 30/09/24 compared to 30/09/23. It details sales growth, organic growth, and structural effects. This format, focusing on key financial highlights for a specific period (Q3/9 months), strongly indicates an Earnings Release (ER). Although it contains some ESG mentions ('CRS commitments'), the primary focus is the financial performance announcement. It is not a comprehensive report (like 10-K or IR) nor a transcript (CT). Given its nature as a preliminary announcement of period results, ER is the most appropriate classification. The document length (4370 chars) is typical for an ER press release. 9M 2024
2024-10-24 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.